Before Asc 606 was Nutra Pharma’s largest revenue line in fiscal 2018, bringing in $126.19K of $130.60K (97%).
| Accounting Standards Update | FY 2018 |
|---|---|
| Before Asc 606 | $126.19K |
| Asc 606 | $4.40K |
| Total | $130.60K |
Nutra Pharma brought in $130.60K from its two revenue lines in fiscal 2018, the year ended December 31, 2018. Before Asc 606 was the largest at $126.19K (96.6%), ahead of Asc 606 at $4.40K (3.4%).
Nutra Pharma (NPHC) reports its revenue by accounting standards update. In fiscal 2018, Before Asc 606 was its largest revenue line, bringing in $126.19K (96.6% of the total), followed by Asc 606 at $4.40K (3.4%).
Before Asc 606 was Nutra Pharma's largest revenue line in fiscal 2018, bringing in $126.19K, or 96.6% of the $130.60K total across its two revenue lines.
Every figure comes from Nutra Pharma's annual financial filings, as reported. Each line keeps the name Nutra Pharma gives it, and years follow its fiscal calendar.
Nutra Pharma's revenue by accounting standards update goes back to fiscal 2018, with figures through fiscal 2018. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.